Cite

    Franchino‐Elder, J. et al. (n.d.). Comparison of healthcare costs among patients with non‐valvular atrial fibrillation treated with warfarin who switched to a novel oral anticoagulant. Journal of pharmaceutical health services research. 11 (2), pp. 133-140. [Online].